Highlights in lung cancer from ASCO 2026: LIBRETTO-432, CROWN, and more
This week, VJOncology brings you lung cancer highlights from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Join Alessandro di Federico from the Memorial Sloan Kettering Cancer Center, Erika Ruiz-Garcia of the Instituto Nacional de Cancerologia, Nandini Menon of the Tate Memorial Centre and Bjorn Henning Gronberg of the Norwegian University of Science and Technology as they discuss key trials and data in lung cancer from the meeting. They explore results from the LIBRETTO-432, TRITON and FLAME trials, as well as 7-year follow up data from the CROWN trial. In addition, they discuss two trials of KRAS G12C inhibitors, a study examining low-dose pembrolizumab and a trial of thoracic radiotherapy.
▶︎
Breast cancer highlights from ASCO 2026
▶︎
Episode 5: Biochemical Recurrence in Prostate Cancer - The View on GU | with Lalani & Wallis
▶︎
He Exposes The Truth About Market Algorithms - Wall Street Insider
▶︎
Nontraditional vs. Overrepresented MBA Applicants | Ep 83
▶︎
Top Tips From MBA Admissions Insiders | Ep 49
▶︎
Howard Hughes Holdings (NYSE: HHH) 2025 Shareholder Meeting
▶︎
Is the AfD a threat to Germany? Mehdi Hasan & Maximilian Krah | Head to Head
▶︎
Cancer and metabolism
▶︎
Bronchoscopy for Lung Cancer: What It’s Really Like (From a Survivor)
▶︎
Antineoplastic Agents | Clinical Medicine
▶︎
Stage IV lung cancer from symptoms to diagnosis | Jaymie shares the beginning of her cancer story.
▶︎
I wore a glucose monitor as a petite. here's what no one tells you about fat loss
▶︎
I Lived Another Life In a Coma | It Happened to Me
▶︎
Ivermectin to Treat Cancer? Get the FACTS
▶︎
My Near Death Experience-Vinney Tolman
▶︎
This DISSOLVES Plaque & UNCLOGS Your Arteries Naturally
▶︎
Spine Surgeon Drowns for 30 Minutes —Comes Back With a List
▶︎
Politics Chat, June 25, 2026
▶︎
My STAGE 4 Lung Cancer Diagnosis Wasn't Part of the Plan!
▶︎